Client News

Sarepta’s Gene Therapy Improved Muscle Function

A great way to start off our week 👏 Today, H+C client Sarepta Therapeutics announced positive clinical results from its investigational #genetherapy for the treatment of #limbgirdle #musculardystrophy Type 2E, one of the many subtypes of LGMD that has no treatment options.



Join The Conversation

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow us on instagram